1. Home
  2. MGX vs GRO Comparison

MGX vs GRO Comparison

Compare MGX & GRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MGX
  • GRO
  • Stock Information
  • Founded
  • MGX 2018
  • GRO 2006
  • Country
  • MGX United States
  • GRO Canada
  • Employees
  • MGX N/A
  • GRO N/A
  • Industry
  • MGX
  • GRO
  • Sector
  • MGX
  • GRO
  • Exchange
  • MGX NYSE
  • GRO NYSE
  • Market Cap
  • MGX 62.1M
  • GRO 57.6M
  • IPO Year
  • MGX 2024
  • GRO 2024
  • Fundamental
  • Price
  • MGX $2.17
  • GRO $1.49
  • Analyst Decision
  • MGX Strong Buy
  • GRO Strong Buy
  • Analyst Count
  • MGX 4
  • GRO 1
  • Target Price
  • MGX $13.00
  • GRO $5.50
  • AVG Volume (30 Days)
  • MGX 912.4K
  • GRO 129.2K
  • Earning Date
  • MGX 08-13-2025
  • GRO 08-03-2025
  • Dividend Yield
  • MGX N/A
  • GRO N/A
  • EPS Growth
  • MGX N/A
  • GRO N/A
  • EPS
  • MGX N/A
  • GRO N/A
  • Revenue
  • MGX $45,263,000.00
  • GRO N/A
  • Revenue This Year
  • MGX N/A
  • GRO N/A
  • Revenue Next Year
  • MGX $11.75
  • GRO N/A
  • P/E Ratio
  • MGX N/A
  • GRO N/A
  • Revenue Growth
  • MGX N/A
  • GRO N/A
  • 52 Week Low
  • MGX $1.23
  • GRO $1.25
  • 52 Week High
  • MGX $5.50
  • GRO $15.00
  • Technical
  • Relative Strength Index (RSI)
  • MGX 71.83
  • GRO N/A
  • Support Level
  • MGX $1.45
  • GRO N/A
  • Resistance Level
  • MGX $2.47
  • GRO N/A
  • Average True Range (ATR)
  • MGX 0.16
  • GRO 0.00
  • MACD
  • MGX 0.09
  • GRO 0.00
  • Stochastic Oscillator
  • MGX 75.47
  • GRO 0.00

About MGX METAGENOMI INC

Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. The genome editing toolbox includes systems for making small edits such as programmable nucleases, base editors, small RNA-mediated integration systems (RIGS), as well as large gene integration systems including large template RIGS and CRISPR-associated transposases (CASTs). The company is focused on its vivo gene editing for its wholly-owned pipeline while pursuing technology out licensing for ex vivo cell therapy. Its pipeline includes product candidates aimed at addressing disorders like Hemophilia A (through MGX-001), Refractory Hypertension, Cardiovascular diseases, and Wilson's disease, among others.

About GRO BRAZIL POTASH CORP

Brazil Potash Corp is a mineral exploration and development company with a potash mining project located in the state of Amazonas, Brazil. The company's technical operations are based in Autazes, Amazonas, Brazil, and Belo Horizonte, Minas Gerais, Brazil. The operating activities of the company include focusing on the extraction and processing of potash ore from the underground mine of the Autazes Project and selling and distributing the processed potash in Brazil.

Share on Social Networks: